Literature DB >> 28891312

Consequences of market withdrawal of fluphenazine and trifluoperazine: Letter to the editor and case series.

Jesse Zanker1, Angelo Ferraro2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28891312     DOI： 10.1177/0004867417730418

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN： 0004-8674            Impact factor:   5.744


× No keyword cloud information.
  2 in total

1.  ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.

Authors:  Chun-Lin Lin; Xi Tan; Meizhen Chen; Meena Kusi; Chia-Nung Hung; Chih-Wei Chou; Ya-Ting Hsu; Chiou-Miin Wang; Nameer Kirma; Chun-Liang Chen; Ching-Hung Lin; Kate I Lathrop; Richard Elledge; Virginia G Kaklamani; Kohzoh Mitsuya; Tim H-M Huang
Journal:  BMC Med Genomics       Date:  2020-05-14       Impact factor: 3.063

2.  Clinical outcomes following switching antipsychotic treatment due to market withdrawal: a retrospective naturalistic cohort study of pipotiazine palmitate injection (Piportil Depot) discontinuation, subsequent acute care use and effectiveness of medication to which patients switched.

Authors:  Rollo J G Sheldon; Marco Pereira; George Aldersley; Tim Sales; Jed Hewitt; Ray Lyon; Richard Whale
Journal:  Ther Adv Psychopharmacol       Date:  2022-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.